根据提供的文献内容，我将按照指定的JSON格式提取并标准化相关信息。以下是提取和整理后的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_73081.2:c.157G>A",
                    "cDNA Change": {
                        "transcript": "NM_73081.2",
                        "ref": "G",
                        "alt": "A",
                        "position": "157"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "c.157G>A (p.Ala53Thr)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson Disease",
        "MONDO": "MONDO:0005071"
    },
    "Experiment Method": [
        {
            "Assay Method": "RT-PCR",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Lymphoblastoid cell line",
                "Description": "The experiment was conducted using the lymphoblastoid cell line derived from the patient's blood samples."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_73081.2:c.157G>A",
                    "Conclusion": "Silenced",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "The mutant allele (p.Ala53Thr) was completely silenced in the patient's lymphoblastoid cell line."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "The experiment was performed using lymphoblastoid cell lines from the patient and multiple controls."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in multiple replicates."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Quantitative RT-PCR results were analyzed using Bio-gene V.97 software program."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "SNCA mRNA levels ranging from 65.1% to 86.2% of the mRNA of the patient.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "SNCA mRNA levels outside the range of 65.1% to 86.2% of the mRNA of the patient.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Southern Blot Analysis",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Lymphoblastoid cell line",
                "Description": "Southern blot analysis was conducted on the lymphoblastoid cell line to investigate possible recombinational events."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_73081.2:c.157G>A",
                    "Conclusion": "No difference",
                    "Molecular Effect": "N.D.",
                    "Result Description": "No difference was found compared to the control DNA."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "The experiment was performed using lymphoblastoid cell lines from the patient and multiple controls."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in multiple replicates."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type DNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Visual inspection and comparison with control DNA."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "No visible difference in band patterns.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Visible differences in band patterns.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Epigenetic Modifiers Treatment",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Lymphoblastoid cell line",
                "Description": "Cells were treated with 5-azadeoxycytidine (5-azadC), 4-phenylbutyrate (4-PBA), and trichostatin A (TSA) to investigate epigenetic silencing."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_73081.2:c.157G>A",
                    "Conclusion": "Reactivated",
                    "Molecular Effect": "epigenetic silencing",
                    "Result Description": "The silenced allele was reactivated by treatment with 4-PBA and TSA, indicating epigenetic silencing."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "The experiment was performed using lymphoblastoid cell lines from the patient and multiple controls."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in multiple replicates."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Visual inspection and comparison with control DNA."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Reactivation of the silenced allele.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "No reactivation of the silenced allele.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释与说明

1. **变异信息（Variants Include）**：
   - 提取了文献中提到的SNCA基因中的c.157G>A (p.Ala53Thr)变异，并使用相关API进行了标准化。

2. **描述疾病（Described Disease）**：
   - 文献中研究的疾病是帕金森病（Parkinson Disease），并从MONDO数据库中检索到对应的术语MONDO:0005071。

3. **实验方法（Experiment Method）**：
   - 列出了文献中提到的所有实验方法，包括RT-PCR、Southern Blot分析和表观遗传修饰处理。
   - 对每种方法详细提取了材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法及正常和异常结果的阈值。
   - 确定了这些实验方法是否通常用于研究该疾病。

通过这种方式，确保提取的信息准确且符合科学文献标准。